These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9484879)

  • 21. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 22. Pharmacokinetic study of a new quinolone, DW-116.
    Lee DK
    Drugs; 1995; 49 Suppl 2():323-5. PubMed ID: 8549349
    [No Abstract]   [Full Text] [Related]  

  • 23. [Grepafloxacin (Raxar)].
    Friis HM
    Ugeskr Laeger; 1998 Jul; 160(30):4438-41. PubMed ID: 9691842
    [No Abstract]   [Full Text] [Related]  

  • 24. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
    Langan CE; Cranfield R; Breisch S; Pettit R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug not considered a first-line agent.
    Lexchin J
    Can Fam Physician; 1998 Nov; 44():2376. PubMed ID: 9839049
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the clinical efficacy and safety of injectable quinolones in the treatment of respiratory tract infections (discussion)].
    Kohno S; Watanabe A; Mikasa K; Asano K
    Jpn J Antibiot; 2003 Apr; 56(2):93-104. PubMed ID: 12825412
    [No Abstract]   [Full Text] [Related]  

  • 27. New uses for new and old quinolones and the challenge of resistance.
    Hooper DC
    Clin Infect Dis; 2000 Feb; 30(2):243-54. PubMed ID: 10671323
    [No Abstract]   [Full Text] [Related]  

  • 28. [The role of respiratory quinolone in treatment of respiratory tract infections: focusing on gatifloxacin].
    Kohno S; Watanabe A; Matsushima T
    Jpn J Antibiot; 2002 Jun; 55(3):247-58. PubMed ID: 12199109
    [No Abstract]   [Full Text] [Related]  

  • 29. [A clinical study on lomefloxacin to find appropriate dose levels in the treatment of respiratory tract infections].
    Shimokata K; Totani Y; Ichiyama S; Saka H; Hasegawa Y; Ikeda T; Yamada Y; Nishiwaki K; Nakanishi K; Taniguchi K
    Jpn J Antibiot; 1993 Jan; 46(1):44-52. PubMed ID: 8384278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety profile of grepafloxacin compared with other fluoroquinolones.
    Stahlmann R; Schwabe R
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():83-92. PubMed ID: 9484877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of fluoroquinolones in respiratory tract infections.
    Grossman RF
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():59-62. PubMed ID: 9484874
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
    O'Doherty B; Dutchman DA; Pettit R; Maroli A
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():73-81. PubMed ID: 9484876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibacterial activity of AM-1155 against penicillin-resistant Streptococcus pneumoniae.
    Tomizawa H; Tateda K; Miyazaki S; Yamaguchi K
    J Antimicrob Chemother; 1998 Jan; 41(1):103-6. PubMed ID: 9511043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A new generation of fluoroquinolones--new possibilities for the treatment of respiratory community-acquired infections].
    Iakovlev SV
    Antibiot Khimioter; 2001; 46(6):38-42. PubMed ID: 11573324
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative field evaluation of marbofloxacin tablets in the treatment of feline upper respiratory infections.
    Dossin O; Gruet P; Thomas E
    J Small Anim Pract; 1998 Jun; 39(6):286-9. PubMed ID: 9673905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of clinical trials with fluoroquinolones with an emphasis on new agents.
    Blondeau JM
    Expert Opin Investig Drugs; 2000 Feb; 9(2):383-413. PubMed ID: 11060684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
    Goldstein EJ
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S25-30. PubMed ID: 8953103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recent fluoroquinolones. Highly effective weapons for ambulatory therapy].
    Stahlmann R; Lode H
    MMW Fortschr Med; 1999 Nov; 141(47):35-6. PubMed ID: 10912165
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of enrofloxacin in the treatment of respiratory pasteurellosis in rabbits.
    Broome RL; Brooks DL
    Lab Anim Sci; 1991 Dec; 41(6):572-6. PubMed ID: 1667200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.